CNC Centene Corp
Company Analysis
Latest News
🔴 Centene is trading 9.09% down in after-hours trading — no verified company-specific catalyst
Centene is trading 9.09% down at $62.40 after hours, with no verified company-specific announcement explaining the move. - The regular-session close was...
Centene Shares Jump on National Gold Card Program Set for November 2026
Centene shares rose as much as 3.5% during the trading session after the company announced a national Gold Card program. The stock closed up 2.8% and reached a...
🔴 Centene is trading 41.12% down in after-hours trading amid a potentially erroneous quote
Centene is trading 41.12% down at $37.26; the extreme after-hours move appears unconfirmed and may reflect an illiquid or erroneous quote. - Centene closed at...
🟢 Centene is trading 5% up today — no clear company-specific catalyst identified
Centene is trading 5.1% up at $67.33, with no clear company-specific catalyst identified for the September 10, 2026 gain. - A September 9 report said the U.S....
🔴 Centene is trading 4.1% down today as investors assess insurance-coverage and ACA-subsidy risks
Centene is trading 4.1% down at $61.94 amid a broader healthcare-sector sell-off as investors assess insurance-coverage and ACA-subsidy risks. • Centene’s...
🟢 Centene is trading 4% up today as healthcare-sector sentiment strengthens on medical-device earnings
Centene is trading 4.02% up at $67.85 as healthcare-sector sentiment strengthened on positive medical-device earnings and a going-private proposal for...
🔴 Centene is trading 4.12% down today after announcing CFO succession
Centene is trading 4.12% down at $64.69 after CFO Andrew Asher’s December 2026 step-down and end-2027 retirement announcement. - Christopher Neczypor,...
Centene Announces CFO Transition and Reaffirms Full-Year 2026 EPS Guidance
Centene Corporation announced that Chief Financial Officer Andrew Asher will retire at the end of 2026, with Christopher Neczypor, former CFO of Lincoln...
🔴 Centene is trading 4.02% down today amid possible enrollment and cost concerns
Centene is trading at $64.30, with a -4.02% change as investors may be reassessing enrollment and cost concerns. - The decline reverses part of the 4.56% gain...
🟢 Centene is trading 4.3% up today as robust earnings and raised guidance fuel a multi-day rally
Centene is trading 4.3% up today at $66.85, extending a multi-day rally driven by robust recent earnings and raised guidance that bolstered investor...
Centene Faces Surging Churn Risk, Following End of Medicare Part D Subsidies
Centene faces a significant risk of customer churn in its standalone Medicare Part D prescription drug plans. This follows the federal government’s decision to...
🔴 Centene is trading 6.8% down today as post-earnings gains evaporate
Centene is trading 6.8% down now at $59.74 after a strong Q2 earnings report failed to hold initial gains. • The company beat estimates and raised full-year...
Centene Crushes Q2 Estimates and Raises Its Outlook — So Why Are Investors Heading for the Exits?
Shares shifted sharply as Centene Corp. dropped 9.1% in pre-market trading to $58.23 despite delivering a blowout second quarter this morning. The paradox — a...
🔴 Centene is trading 9.1% down today despite Q2 beat and raised guidance
Centene is trading 9.1% down at $58.23 as investors reassess the company's margin trajectory and updated guidance following its Q2 2026 earnings report. • The...
Centene's second quarter 2026 earnings crushed estimates, leading to a raised full-year outlook.
Centene reported second quarter 2026 total revenues of $53.6 billion and GAAP EPS of $2.19, significantly exceeding analyst expectations. The company's Health...
Centene Corp Q2 2026 Earnings Preview: What Analysts Expect on July 28, 2026
Centene Corporation is expected to report Q2 2026 revenue of $47.53 billion and earnings per share of $0.89, with its current price of $63.35 trading slightly...
Centene Shares Sink, Pressured by $1 Billion Medicaid Payment Freeze
Centene shares fell sharply on July 23, 2026, following new regulatory challenges to its Medicaid business. The Centers for Medicare & Medicaid Services...
Centene awards Cognizant $1 billion contract to automate healthcare operations
Centene Corp awarded a multi-year technology services contract to Cognizant. The deal is valued at more than $500 million and could potentially reach $1...
🟢 Centene is trading 4% up today as UnitedHealth results lift healthcare sector
Centene is trading 4% up at $66.45, rebounding from recent weakness as strong UnitedHealth earnings boost sentiment across the managed care space. • The stock...
Centene faces membership risk, as new law doubles Medicaid eligibility checks
A 2025 federal law will require states to verify Medicaid eligibility every six months. This mandate doubles the current annual frequency for adults aged 19-64...